Return to search

Liver Drug Startup Snares Series A

Conatus Pharmaceuticals Inc., a San Diego-based drug developer focused on liver disease, has secured $6.62 million of a $27.37 million Series A round, according to a regulatory filing. Backers include Aberdare Ventures, Bay City Capital, Advent International and Hale BioPharma Ventures. www.conatuspharma.com